Tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer: An updated series

Gynecologic Oncology

Volumn 117, Issue 2, 2010, Pages 330-335

  Shih, K K ^a   Chi, D S ^a   Barakat, R R ^a   Leitao Jr , M M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Epithelial ovarian cancer; Fallopian tube cancer; Primary peritoneal cancer; Recurrence; Surgical cytoreduction; Tertiary cytoreduction

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; CYTOREDUCTIVE SURGERY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PERITONEUM CANCER; PRIORITY JOURNAL; PROGNOSIS; RECURRENT CANCER; UTERINE TUBE TUMOR;

ADULT; AGED; FALLOPIAN TUBE NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 77950188150     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.01.046     Document Type: Article

References (28)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics. CA Cancer J Clin. 58 (2008) 71-96
2. Eisenkop S.M., Friedman R.L., and Wang H.J. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study. Gynecol Oncol. 69 (1998) 103-108
3. Muggia F.M., Braly P.S., Brady M.F., et al. Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study. J Clin Oncol. 18 (2000) 106-115
4. Griffiths C.T. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Natl Cancer Inst Monogr. 42 (1975) 101-104
5. Hacker N.F., Berek J.S., Lagasse L.D., Nieberg R.K., and Elashoff R.M. Primary cytoreductive surgery for epithelial ovarian cancer. Obstet Gynecol. 61 (1983) 413-420
6. Piver M.S., Lele S.B., Marchetti D.L., et al. The impact of aggressive debulking surgery and cisplatin-based chemotherapy on progression-free survival in stage III and IV ovarian carcinoma. J Clin Oncol. 6 (1988) 983-989
7. Hoskins W.J., Bundy B.N., Thigpen J.T., and Omura G.A. The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study. Gynecol Oncol. 47 (1992) 159-166
8. Hoskins W.J., McGuire W.P., Brady M.F., et al. The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol. 170 (1994) 974-979
9. Bristow R.E., Tomacruz R.S., Armstrong D.K., Trimble E.L., and Montz F.J. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol. 20 (2002) 1248-1259
10. Fader A.N., and Rose P.G. Role of surgery in ovarian carcinoma. J Clin Oncol. 25 (2007) 2873-2883
11. Chi D.S., Eisenhauer E.L., Lang J., et al. What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?. Gynecol Oncol. 103 (2006) 559-564
12. Morris M., Gershenson D.M., and Wharton J.T. Secondary cytoreductive surgery in epithelial ovarian cancer: nonresponders to first-line therapy. Gynecol Oncol. 33 (1989) 1-5
13. Morris M., Gershenson D.M., and Wharton J.T. Secondary cytoreductive surgery for recurrent epithelial ovarian cancer. Gynecol Oncol. 34 (1989) 334-338
14. Segna R.A., Dottino P.R., Mandeli J.P., Konsker K., and Cohen C.J. Secondary cytoreduction for ovarian cancer following cisplatin therapy. J Clin Oncol. 11 (1993) 434-439
15. Eisenkop S.M., Friedman R.L., and Wang H.J. Secondary cytoreductive surgery for recurrent ovarian cancer. A prospective study. Cancer 76 (1995) 1606-1614
16. Vaccarello L., Rubin S.C., Vlamis V., et al. Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response. Gynecol Oncol. 57 (1995) 61-65
17. Eisenkop S.M., Friedman R.L., and Spirtos N.M. The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma. Cancer 88 (2000) 144-153
18. Gadducci A., Iacconi P., Cosio S., et al. Complete salvage surgical cytoreduction improves further survival of patients with late recurrent ovarian cancer. Gynecol Oncol. 79 (2000) 344-349
19. Zang R.Y., Zhang Z.Y., Li Z.T., et al. Impact of secondary cytoreductive surgery on survival of patients with advanced epithelial ovarian cancer. Eur J Surg Oncol. 26 (2000) 798-804
20. Tay E.H., Grant P.T., Gebski V., and Hacker N.F. Secondary cytoreductive surgery for recurrent epithelial ovarian cancer. Obstet Gynecol. 99 (2002) 1008-1013
21. Gungor M., Ortaç F., Arvas M., Kösebay D., Sönmezer M., and Köse K. The role of secondary cytoreductive surgery for recurrent ovarian cancer. Gynecol Oncol. 97 (2005) 74-79
22. Chi D.S., McCaughty K., Diaz J.P., et al. Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma. Cancer 106 (2006) 1933-1939
23. Salani R., Santillan A., Zahurak M.L., et al. Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: analysis of prognostic factors and survival outcome. Cancer 109 (2007) 685-691
24. Oksefjell H., Sandstad B., and Trope C. The role of secondary cytoreduction in the management of the first relapse in epithelial ovarian cancer. Ann Oncol. 20 (2009) 286-293
25. Leitao M.M., Kardos S., Chi D.S., and Barakat R. Tertiary cytoreduction in patients with recurrent ovarian carcinoma. Gynecol Oncol. 95 (2004) 181-188
26. Karam A.K., Santillan A., Bristow R.E., et al. Tertiary cytoreductive surgery in recurrent ovarian cancer: selection criteria and survival outcome. Gynecol Oncol. 104 (2007) 377-380
27. Benedet J.L., Bender H., Jones III H., Ngan H.Y., and Pecorelli S. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet. 70 (2000) 209-262
28. Berek J.S., Hacker N.F., Lagasse L.D., Nieberg R.K., and Elashoff R.M. Survival of patients following secondary cytoreductive surgery in ovarian cancer. Obstet Gynecol. 61 (1983) 189-193